Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile?

Literature DB >> 16247100

How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile?

Thomas J Louie¹.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2005 PMID： 16247100 PMCID： PMC1266328 DOI： 10.1503/cmaj.051212

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

10 in total

1. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem.

Authors: Dale N Gerding
Journal: Clin Infect Dis Date: 2004-02-11 Impact factor: 9.079

2. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors: Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal: CMAJ Date: 2005-09-22 Impact factor: 8.262

3. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors: Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal: Lancet Date: 2005 Sep 24-30 Impact factor: 79.321

4. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.

Authors: S Johnson; M H Samore; K A Farrow; G E Killgore; F C Tenover; D Lyras; J I Rood; P DeGirolami; A L Baltch; M E Rafferty; S M Pear; D N Gerding
Journal: N Engl J Med Date: 1999-11-25 Impact factor: 91.245

5. Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. difficile-associated diarrhoea.

Authors: Jim van Steenbergen; Sylvia Debast; Eric van Kregten; Renate van den Berg; Daan Notermans; Ed Kuijper
Journal: Euro Surveill Date: 2005-07-14

6. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors: Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal: CMAJ Date: 2004-08-31 Impact factor: 8.262

7. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost.

Authors: M W Climo; D S Israel; E S Wong; D Williams; P Coudron; S M Markowitz
Journal: Ann Intern Med Date: 1998-06-15 Impact factor: 25.391

8. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors: Patrizia Spigaglia; Paola Mastrantonio
Journal: J Clin Microbiol Date: 2002-09 Impact factor: 5.948

9. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain.

Authors: M R Popoff; E J Rubin; D M Gill; P Boquet
Journal: Infect Immun Date: 1988-09 Impact factor: 3.441

10. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors: Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal: CMAJ Date: 2004-07-06 Impact factor: 8.262